Hoʻolālā ka haʻawina hou i ka hiki o Masimo EMMA® Capnography e loiloi i ke kūlana hanu i nā keiki Tracheostomy

Neuchatel, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) i kēia lā ua hoʻolaha i nā hopena o kahi noiʻi retrospective nānā i paʻi ʻia ma ka International Journal of Pediatrics. Hiki ke hoʻohana ʻia ka capnometer portable Masimo EMMA® e nānā i ke kūlana hanu o nā keiki e hana ana i ka tracheotomy. ʻaʻohe calibration maʻamau, liʻiliʻi ka manawa pumehana, a hōʻike pololei i ka end-tidal carbon dioxide (EtCO2) a me nā ana o ka hanu a me ka hawewe EtCO2 mau i loko o 15 kekona.
Ma ka ʻike ʻana i ka waiwai kūpono o kahi ala paʻa a paʻa e nānā ai i nā loli i ke kūlana hanu o nā maʻi i nā kūlana i loaʻa ʻole ai nā lako mālama mālama hale maʻi maʻamau, ʻimi ʻo Kauka Masashi Hotta a me nā hoa hana e loiloi i ka pono o ka EMMA capnography i nā keiki ma ka hoʻohālikelike ʻana. ʻikepili mai nā waiwai EtCO2 mai ka mea EMMA (i hoʻopili ʻia i ka ʻaoʻao mamao o ka pahu tracheostomy) a me ke ana invasively ana i ke kaomi ʻāpana venous o carbon dioxide (PvCO2) no ka tracheotomy. maʻamau no ka loiloi ʻana i ke kūlana hanu, ua koho nā mea noiʻi iā PvCO2 no ka mea "ʻoi aku ka invasive o ka lawe ʻana i nā laʻana arterial ma mua o ka lawe ʻana i nā laʻana venous," me ka ʻike ʻana ua hōʻike nā haʻawina e PaCO2 a me PvCO2.2,3 Ua kiʻi lākou i nā pēpē 9 (median makahiki 8 mahina) a hoʻohālikelike i kahi ka huina o 43 mau paihelu EtCO2-PvCO2.
Ua loaʻa i nā mea noiʻi kahi helu hoʻopili ma waena o EtCO2 a me PvCO2 heluhelu o 0.87 (95% hilinaʻi manawa 0.7 - 0.93; p <0.001) . % ka palena aelike he 1.0 – 19.1 mmHg). Mana'o ka poe noi'i e hiki ke wehewehe 'ia ke ano o ka EtCO2 ma mua o PvCO2 ma o ka hui 'ana o ke kinoea ma kahi kokoke i ka pahu tracheostomy ma muli o ka loa'a 'ana o kahi anatomical and physiological dead space. ʻO nā paipu me ka ʻole o ka ʻūhā, ua hiki mai paha kēia ʻO kekahi mau leaks, a ma kahi o ʻelua hapakolu o ka poʻe maʻi i loaʻa i ka [chronic lung disease or bronchopulmonary dysplasia], a lākou e kuhikuhi nei ua hōʻike ʻia e hāʻawi i ka CO2 i ka wā o ka exhalation i hoʻohālikelike ʻia me ke kaomi hapa o CO2 i loko o ke koko Ua emi iho ka nui.
Ua ʻike pū lākou he ʻoi aku ka nui o nā ʻokoʻa ma waena o nā heluhelu i hōʻiliʻili ʻia i ka wā e loaʻa ana nā mea maʻi i ka ea uila (28 o 43 mau pālua data). (p = 0.043) Ua ʻike ka poʻe noiʻi ua pili nui ka hoʻohana ʻana i ka ventilator me nā ʻokoʻa o ka heluhelu paʻa ʻana no ka mea ua loaʻa i nā mea maʻi ma luna o nā ventilator nā kūlana hanu a i ʻole ke kahe.
"Ke hōʻike nei mākou i kahi pilina maikaʻi ma waena o PvCO2 a me EtCO2 a hōʻike i ka hoʻohana ʻana a me ka pono o kēia capnometer no nā keiki e hana ana i ka tracheotomy," i hoʻopau ai nā mea noiʻi, "hiki ke hoʻohana ʻia ʻo EMMA no ka loiloi ʻana i ke kūlana hanu o nā keiki e hana ana i ka tracheotomy. nā hoʻonohonoho mālama home a me nā hoʻonohonoho maʻi waho no ia mau keiki."Ua ʻike pū lākou, "ʻO ka ikaika nui o kēia haʻawina ʻo ia kā mākou hoʻohana ʻana i kahi capnometer portable e loiloi iā EtCO2."
ʻO Masimo (NASDAQ: MASI) kahi hui ʻenehana lapaʻau honua e hoʻomohala a hana i kahi ākea ākea o nā ʻenehana nānā alakaʻi i ka ʻoihana, me nā ana ʻano hou, nā mea ʻike, nā mākaʻi maʻi, a me ka automation a me nā hoʻonā hoʻohui. ʻO ka Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximeter i hōʻoia i kāna hana ma luna o nā ʻenehana pulse oximeter ʻē aʻe ma mua o 100 mau haʻawina kūʻokoʻa a me ka pahuhopu. i hōʻike ʻia e kōkua i nā kauka e hōʻemi i ka retinopathy koʻikoʻi i nā pēpē preterm, 5 e hoʻomaikaʻi i ka nānā ʻana i ka CCHD i nā neonates, 6 a hōʻemi i ka hoʻoikaika hui pane wikiwiki i ka wā e hoʻohana ai iā Masimo Patient SafetyNet ™ no ka nānā mau ʻana i ka papa post-operative.ʻO ka hoʻouluʻana, nā hoʻoili ICU a me nā koina.7-10 manaʻo e hoʻohana ʻia ʻo Masimo SET® e ʻoi aku ma mua o 200 miliona mau mea maʻi ma ke alakaʻi ʻana i nā haukapila a me nā keʻena mālama olakino ʻē aʻe a puni ka honua,11 e like me ka 2020-21 US News & World Report Best Hospitals Honor. ʻO Roll,11 a ʻo ia kekahi o nā halemai 10 kiʻekiʻe o 9 mau pulse oximeters.12 Ke hoʻomau nei ʻo Masimo i ka hoʻomaikaʻi ʻana i ka SET®, a i ka makahiki 2018 ua hoʻolaha ʻo RD SET® sensor's SpO2 pololei ma lalo o nā kūlana neʻe i hoʻomaikaʻi nui ʻia, e hāʻawi ana i nā kauka me ka hilinaʻi nui aʻe. ʻO nā koina SpO2 ke hilinaʻi nei lākou i ka hōʻike pololei ʻana i ke kūlana physiological o ka mea maʻi. I ka makahiki 2005, ua hoʻokomo ʻo Masimo i ka ʻenehana ʻo Rainbow® Pulse CO-Oximetry, kahi e hiki ai ke nānā pono ʻole a hoʻomau i ka nānā ʻana i nā ʻāpana koko i ana mua ʻia, me ka huina hemoglobin (SpHb® ), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), Methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi) a me Oxygen Reserve Index (ORi™). ʻO ka Root® Patient Monitoring and Connectivity Platform, i kūkulu ʻia mai ka honua a hiki ke maʻalahi a hiki ke hoʻonui ʻia e hiki ai ke hoʻohui i nā ʻenehana nānā ʻē aʻe o Masimo a me nā ʻaoʻao ʻekolu;ʻO nā mea hoʻohui koʻikoʻi iā Masimo e komo pū me ka SedLine® Brain function monitoring, O3® regional oxygen saturation a me ISA™ capnography me NomoLine® sampling line. hoʻohana ʻia i nā ʻano hiʻohiʻona ʻokoʻa a me ka ʻole o ka clinical, me nā ʻenehana hiki ke hoʻohana ʻole ʻia e like me Radius-7® a me Radius PPG™, nā mea lawe lima e like me Rad-67™, Fingertip pulse oximeters e like me ka MightySat® Rx a me nā mea hiki ke hoʻohana ʻia. hoʻohana ʻia ma ka haukapila a ma ka home e like me ka Rad-97®.Masimo hospital automation and connectivity solutions i hoʻokumu ʻia ma ke kahua ʻo Masimo Hospital Automation™ platform a me Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView ™, UniView:60 ™ a me Masimo SafetyNet ™. No ka ʻike hou aku e pili ana iā Masimo a me kāna mau huahana, e kipa www.masimo.com. /.
ʻAʻole i loaʻa iā ORi a me RPVi ka ʻae a FDA 510 (k) a ʻaʻole hiki ke kūʻai ʻia ma ʻAmelika Hui Pū ʻIa.
Aia kēia hoʻolaha paʻi i nā ʻōlelo e nānā ana i mua i loko o ke ʻano o ka Pauku 27A o ka Securities Act o 1933 a me ka Pauku 21E o ke Securities Exchange Act o 1934 e pili ana i ka Private Securities Litigation Reform Act o 1995. ʻO kēia mau ʻōlelo e nānā mua nei: , nā ʻōlelo e pili ana i ka pono kūpono o EMMA®. Hoʻokumu ʻia kēia mau ʻōlelo i mua i nā manaʻolana o kēia wā e pili ana i nā hanana e hiki mai ana e pili ana iā mākou a pili i nā pilikia a me ka maopopo ʻole, paʻakikī nā mea āpau e wānana, ʻo ka nui o ia mau mea ma waho o ko mākou mana a hiki ʻokoʻa i kā mākou hopena maoli mai nā mea ma muli o nā pilikia like ʻole.pili i ko mākou manaʻoʻiʻo ʻo Masimo nā ʻenehana ana non-invasive ʻokoʻa, me ka EMMA, kōkua i nā pilikia lapaʻau maikaʻi e pili ana i nā hopena a me ka palekana hoʻomanawanui;nā pilikia e pili ana i ko mākou manaʻoʻiʻo e hāʻawi nā hōʻailona lapaʻau non-invasive ʻo Masimo i nā hoʻonā kumu kūʻai a me nā pono kūʻokoʻa;nā pilikia e pili ana me COVID-19;a me kā mākou waihona me ka Securities and Exchange Commission ("SEC") ʻO nā kumu hou aʻe i kūkākūkā ʻia ma ka ʻāpana "Risk Factors" o ka hōʻike hou loa e loaʻa manuahi ʻole ma ka pūnaewele SEC ma www.sec.gov. ʻOiai mākou manaʻoʻiʻo nā manaʻo ʻike ʻia i loko o kā mākou mau ʻōlelo i mua he kūpono, ʻaʻole mākou i ʻike inā e hōʻoia ʻia kā mākou mau manaʻo i ka pololei. kau i ka hilinaʻi pono ʻole i kēia mau ʻōlelo i mua, e ʻōlelo wale nei i kēia lā. , nā hanana e hiki mai ana a i ʻole nā ​​​​mea ʻē aʻe, koe wale nō ke koi ʻia ma lalo o nā kānāwai palekana pili.
ʻIke ʻia kahi noiʻi hou hiki ke hoʻohana ʻia ka Masimo EMMA® Capnograph e loiloi i ka hanu ʻana i nā keiki me ka tracheostomy.

  • Mua:
  • Aʻe:

  • Ka manawa hoʻouna: Iune-20-2022